Close Menu
MarketForces AfricaMarketForces Africa
    What's Hot

    Fitch Affirms Côte d’Ivoire Rating at ‘BB’, Outlook Stable

    June 15, 2026

    Money Market Rates Mixed as Banking System Liquidity Dips

    June 15, 2026

    CBN to Open N1trn Worth of Treasury Bills for Subscription

    June 15, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Fitch Affirms Côte d’Ivoire Rating at ‘BB’, Outlook Stable
    • Money Market Rates Mixed as Banking System Liquidity Dips
    • CBN to Open N1trn Worth of Treasury Bills for Subscription
    • CBN Raises N3.8trn in OMO Bills Sales to Banks, FPIs
    • Naira Opens Weak, Foreign Investors Drive $0.93bn FX Inflows
    • South African Rand Firmer as ‘Peace Deal’ Shifts Market Sentiment
    • Global Equities Markets Rally on AI Momentum, SpaceX IPO Debut
    • Anthropic Restricts Access to Fable, Mythos 5 AI Models after US Order
    • Home
    • About Us
    Facebook X (Twitter) Instagram
    MarketForces AfricaMarketForces Africa
    Subscribe
    Monday, June 15
    • Home
    • News
    • Analysis
    • Economy
    • Mobile Banking
    • Entrepreneurship
    MarketForces AfricaMarketForces Africa
    MarketForces Africa » MarketForces News » COVID-19: Chloroquine phosphate 250mg tablets is fake, NAFDAC warns

    COVID-19: Chloroquine phosphate 250mg tablets is fake, NAFDAC warns

    Marketforces AfricaBy Marketforces AfricaApril 6, 2020Updated:October 11, 2025 News No Comments2 Mins Read
    NAFDAC
    Share
    Facebook Twitter LinkedIn Pinterest Email

    COVID-19: Chloroquine phosphate 250mg tablets is fake, NAFDAC warns

    The National Agency for Food and Drug Administration and Control (NAFDAC) has warned that chloroquine phosphate 250mg tablets with NAFDAC No: 028060 is fake.

    The agency on Monday alerted Nigerians about the falsified chloroquine phosphate 250mg tablets which is already in circulation.

    In a statement the Director-General of the agency, Prof Mojisola Adeyeye, said that NAFDAC was notified by the World Health Organisation (WHO) of the circulation of the tablets in Cameroon.

    “The falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc., Astral pharmaceutical New Bhupalpura, China.

    “The tablets manufactured by these companies has no Active Pharmaceutical Ingredient (API) and are in packs of 1000 tablets.

    “The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure and could even cause death,” she warned.

    She also said that the labelling information on the falsified chloroquine phosphate 250mg tablets manufactured by Jiangsu pharmaceutical Inc., China is labelled with fake NAFDAC No.: 028060.

    “The Astral pharmaceuticals, New Bhupalpura, China is labelled with fake NAFDAC registration No. 0587612 and advised the general public to be aware of this drug.

    “All importers, wholesalers and retailers are hereby cautioned to desist from illegal importation, distribution and sale of falsified chloroquine phosphate 250mg tablets.

    “NAFDAC has strengthened its surveillance in all ports of entry to prevent illegal importation of the falsified chloroquine phosphate 250mg tablets.

    “The agency has also heightened surveillance in the 36 states and the Federal Capital Territory (FCT) to prevent distribution and sale of this falsified drug.

    “Healthcare providers and other members of public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified chloroquine,” she said.

    She called on anybody in possession of the falsified chloroquine to submit it to the nearest NAFDAC office.

    Meanwhile, NAFDAC advised the consumer to report adverse events related with the use of the medicine, or call the agency toll free lines: 0800-1-NAFDAC and 0800-1-623322

    COVID-19: Chloroquine phosphate 250mg tablets is fake, NAFDAC warns

     

    Chloroquine Director-General of the agency NAFDAC Prof Mojisola Adeyeye
    Marketforces Africa
    • Website
    • Facebook
    • X (Twitter)
    • Instagram
    • LinkedIn

    MarketForces Africa, a Financial News Media Platform for Strategic Opinions about Economic Policies, Strategy & Corporate Analysis from today's Leading Professionals, Equity Analysts, Research Experts, Industrialists and, Entrepreneurs on the Risk and Opportunities Surrounding Industry Shaping Businesses and Ideas.

    Keep Reading

    Fitch Affirms Côte d’Ivoire Rating at ‘BB’, Outlook Stable

    Money Market Rates Mixed as Banking System Liquidity Dips

    CBN to Open N1trn Worth of Treasury Bills for Subscription

    CBN Raises N3.8trn in OMO Bills Sales to Banks, FPIs

    Naira Opens Weak, Foreign Investors Drive $0.93bn FX Inflows

    South African Rand Firmer as ‘Peace Deal’ Shifts Market Sentiment

    Add A Comment

    Comments are closed.

    Editors Picks

    Fitch Affirms Côte d’Ivoire Rating at ‘BB’, Outlook Stable

    June 15, 2026

    Money Market Rates Mixed as Banking System Liquidity Dips

    June 15, 2026

    CBN to Open N1trn Worth of Treasury Bills for Subscription

    June 15, 2026

    CBN Raises N3.8trn in OMO Bills Sales to Banks, FPIs

    June 15, 2026

    Naira Opens Weak, Foreign Investors Drive $0.93bn FX Inflows

    June 15, 2026
    Latest Posts

    Fitch Affirms Côte d’Ivoire Rating at ‘BB’, Outlook Stable

    June 15, 2026

    Money Market Rates Mixed as Banking System Liquidity Dips

    June 15, 2026

    CBN to Open N1trn Worth of Treasury Bills for Subscription

    June 15, 2026

    CBN Raises N3.8trn in OMO Bills Sales to Banks, FPIs

    June 15, 2026

    Naira Opens Weak, Foreign Investors Drive $0.93bn FX Inflows

    June 15, 2026

    Subscribe to News

    Get the latest sports news from Dmarketforces Africa about finance, business and tech.

    Advertisement
    Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

    News

    • World
    • Politics
    • Economy
    • Business
    • Opinions
    • Fintech
    • Science & Technology

    Company

    • About us
    • Advertising
    • Classified Ads
    • Contact Info
    • Editorial Policy

    Services

    • Subscriptions
    • Research
    • Due Diligence
    • Newsletters
    • Sponsored News
    • Work With Us

    Subscribe to Updates

    Subscribe to updates from MarketForces Africa, an independent financial news service provider.

    © 2026 MarketForces Africa. All rights reserved.
    • Privacy Policy
    • Terms
    • Accessibility

    Type above and press Enter to search. Press Esc to cancel.